FMO5 and myocardial ischemia: This is the first study defining the molecular mechanisms by which adiponectin suppresses NADPH oxidase activity in the human heart, but these findings are still unable to explain the positive association observed between myocardial redox state and ADIPOQ gene expression in EpAT in patients with IHD.